| Date:13/05/2025 | Title:ChloraPrep 2% w/v 70% v/v Cutaneous Solution, PA2287/001/002, Batch Recall, One batch | Product:Medicines for human use | Type:Recall |
| Date:08/05/2025 | Title:PRAC meeting highlights 05 - 08 May 2025 | Product:Medicines for human use | Type:Pharmacovigilance risk assessment committee (PRAC) |
| Date:15/04/2025 | Title:Epilim Intravenous 400 mg powder and solvent for solution for injection or infusion, Corrected reconstitution instructions | Product:Medicines for human use | Type:Product information update (PIU) |
| Date:10/04/2025 | Title:PRAC meeting highlights 07 -10 April 2025 | Product:Medicines for human use | Type:Pharmacovigilance risk assessment committee (PRAC) |
| Date:25/03/2025 | Title:Drug Safety Newsletter – Edition 118 – 25 March 2025 | Product:Medicines for human use | Type:Safety update |
| Date:14/03/2025 | Title:PRAC meeting highlights 10-13 March 2025 | Product:Medicines for human use | Type:Pharmacovigilance risk assessment committee (PRAC) |
| Date:12/03/2025 | Title:Update to Zovirax IV dosing regimen | Product:Medicines for human use | Type:Medicines for human use |
| Date:06/03/2025 | Title:Neupogen® 30 MU (0.3 mg/ml) Solution for injection filgrastim, PA 1026/001/001, Batch Recall | Product:Medicines for human use | Type:Recall |
| Date:28/02/2025 | Title:Risperidone (Risperdal®, Rispone®) 1 mg/ml Oral Solution: Risk of medication errors leading to accidental overdoses in children and adolescents | Product:Medicines for human use | Type:Direct healthcare professional communication (DHPC) |
| Date:14/02/2025 | Title:PRAC meeting highlights 10-13 February 2025 | Product:Medicines for human use | Type:Pharmacovigilance risk assessment committee (PRAC) |
